Tazoxyn Injection

Tazoxyn 2 gm + 250 mg/vial Injection সম্পর্কে

Tazoxyn হলো Piperacillin + Tazobactam-এর একটি ব্র্যান্ড, শক্তি ২ gm + ২৫০ mg/vial, ইনজেকশন আকারে। Piperacillin + Tazobactam-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। Tazoxyn প্রস্তুত করেছে Advanced Chemical Industries PLC। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।

Piperacillin + Tazobactam-এর ৮টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Brodactam (2 gm+0.25 gm)/vial IV Infusion-এর, প্রতি ইউনিট ৳ ৬০২.০০।

Tazoxyn 2 gm + 250 mg/vial Injection কী?

Tazoxyn is a prescription-only antibiotic injection that combines piperacillin, a penicillin-type antibacterial, with tazobactam, which blocks enzymes that some bacteria use to resist penicillins. Together they are used for moderate to severe bacterial infections caused by organisms that are susceptible to the combination. Because it is given as an intravenous infusion, it is used under medical supervision. The doctor decides whether it is suitable, the dose, and how long the course lasts. It is not an antibiotic for viral illnesses such as the common cold.

Tazoxyn-এর ব্যবহার

Tazoxyn is used to treat moderate to severe infections caused by bacteria that are susceptible to piperacillin and tazobactam, including intra-abdominal infections. It belongs to a group of beta-lactam antibiotics and works by killing bacteria rather than just slowing their growth. It is not effective against viruses. Your doctor will confirm whether this medicine is appropriate for your infection.

Tazoxyn কীভাবে ব্যবহার করবেন

Tazoxyn is given by intravenous infusion, usually over a period of time set by the healthcare team, in a hospital or clinic. A doctor or nurse prepares and administers it. Do not try to use it at home. The doctor decides the dose, how often it is given, and how long the course lasts. Tell the healthcare team about any allergies before treatment and report any reaction during the infusion.

Tazoxyn-এর পার্শ্বপ্রতিক্রিয়া

Side effects that have been reported include rash, itching, purpura, diarrhoea, constipation, nausea, vomiting, indigestion, abdominal pain, fever, injection site reactions, chills, and hypersensitivity reactions. Serious allergic reactions including anaphylaxis can occur. Stop and seek urgent medical help if you have swelling of the face or throat, difficulty breathing, a widespread or worsening rash, or severe diarrhoea. Tell your doctor about any side effect.

সতর্কতা ও নিরাপত্তা

Tazoxyn must not be used by anyone with a history of allergic reactions to penicillins, cephalosporins, or beta-lactamase inhibitors. Serious allergic and severe skin reactions have been reported, so treatment is stopped if a reaction occurs. Blood counts may need monitoring during prolonged therapy. In pregnancy, there is not enough information to judge the risk of birth defects or miscarriage, and piperacillin passes into breast milk. Ask your doctor before use if you are pregnant, breastfeeding, or have kidney problems.

সাধারণ প্রশ্ন

What side effects should I watch for, and when should I call the doctor?

Watch for rash, itching, fever, nausea, vomiting, diarrhoea, or a reaction at the injection site. Get urgent help for swelling of the face or throat, breathing difficulty, a spreading rash, or severe diarrhoea. Tell your doctor about any side effect, especially if it worsens.

What is Tazoxyn used for and what kind of medicine is it?

Tazoxyn is a combination antibiotic containing piperacillin and tazobactam. It is used for moderate to severe bacterial infections, including intra-abdominal infections, caused by bacteria that are susceptible to it. It is not used for viral infections. Your doctor will decide if it is right for you.

What do the dosage form and strength mean?

Tazoxyn comes as an injection supplied as a vial containing 2 gm of piperacillin and 250 mg of tazobactam. It is given by intravenous infusion by a healthcare professional. The doctor decides the dose and course; do not use it yourself at home.

Who should ask a doctor before receiving Tazoxyn?

Anyone with a previous allergic reaction to penicillins, cephalosporins, or beta-lactamase inhibitors should tell the doctor, as should pregnant or breastfeeding women and people with kidney problems. The doctor will assess whether it is suitable and will monitor you during treatment.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Piperacillin and tazobactam is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the ... Read morePiperacillin and tazobactam is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below.

Intra-abdominal Infections: Appendicitis (complicated by rupture or abscess) and peritonitis caused by β-lactamase producing isolates of Escherichia coli or the following members of the Bacteroides fragilis group: B. fragilis, B. ovatus, B. thetaiotaomicron, or B. vulgatus.

Skin and Skin Structure Infections: Uncomplicated and complicated skin and skin structure infections, including Cellulites, cutaneous abscesses and ischemic/diabetic foot infections caused by β-lactamase producing isolates of Staphylococcus aureus.

Female Pelvic Infections: Postpartum endometritis or pelvic inflammatory disease caused by β-lactamase producing isolates of Escherichia coli.

Community-acquired pneumonia: Community-acquired pneumonia (moderate severity only) caused by β lactamase producing isolates of Haemophilus influenzae.

Nosocomial pneumonia: Nosocomial pneumonia (moderate to severe) caused by β-lactamase producing isolates of Staphylococcus aureus and by piperacillin/tazobactam-susceptible Acinetobacter baumanii, Haemophilus influenzae, Klebsiella pneumoniae, and Pseudomonas aeruginosa (Nosocomial pneumonia caused by P. aeruginosa should be treated in combination with an aminoglycoside).

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Piperacillin, a broad spectrum, semi-synthetic penicillin active against many gram-positive and gram-negative aerobic and anaerobic bacteria, exerts bactericidal activity by inhibition of both septum and cell wall synthesis. Tazobactam is a potent inhibitor of many beta-lactamases, including the plasmid and chromosomally mediated enzymes that commonly cause resistance to penicillins. Tazobactam enhances and extends the antibiotic spectrum of Piperacillin to include many beta-lactamase-producing bacteria normally resistant to it. Thus, this infusion combines the properties of a broad-spectrum antibiotic and a beta-lactamase inhibitor.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Piperacillin and tazobactam should be administered by intravenous infusion over 30 minutes.

Adult Patients: The usual total daily dose of Piperacillin and tazobactam for adults is 3.375 g every six hours totaling 13.5 g (12.0 g piperacillin/1.5 g tazobactam). The usual duration of treatment is from 7 to 10 days.

Nosocomial Pneumonia: Initial presumptive treatment of patients with nosocomial pneumonia should start with piperacillin and tazobactam at a dosage of 4.5 g every six hours plus an aminoglycoside, totaling 18.0 g (16.0 g piperacillin/2.0 g tazobactam). The recommended duration of the treatment for nosocomial pneumonia is 7 to 14 days. Treatment with the aminoglycoside should be continued in patients from whom Pseudomonas aeroginosa is isolated.

Pediatric Patients: For children with appendicitis and/or peritonitis 9 months of age or older, weighing up to 40 kg, and with normal renal function, the recommended piperacillin and tazobactam dosage is 100 mg piperacillin/12.5 mg tazobactam per kilogram of body weight, every 8 hours. For pediatric patients between 2 months and 9 months of age, the recommended dosage based on Pharmacokinetic modeling, is 80 mg piperacillin/10 mg tazobactam per kilogram of body weight, every 8 hours. Pediatric patients weighing over 40 kg and with normal renal function should receive the adult dose. It has not been determined how to adjust piperacillin and tazobactam dosage in pediatric patients with renal impairment.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Aminoglycosides: Piperacillin may inactivate aminoglycosides by converting them to microbiologically inert amides. When aminoglycosides are administered in conjunction with piperacillin to patients with end-stage renal disease requiring hemodialysis, the concentrations of the aminoglycosides (especially tobramycin) may be significantly reduced and should be monitored.

Sequential administration of pipercillin and tazobactam and tobramycin to patients with either normal renal function or mild to moderate renal impairment has been shown to modestly decrease serum concentrations of tobramycin but no dosage adjustment is considered necessary.

Probenecid: Probenecid administered concomitantly with piperacillin and tazobactam prolongs the half-life of piperacillin by 21% and that of tazobactam by 71% because probenecid inhibits tubular renal secretion of both piperacillin and tazobactam. Probenecid should not be co-administered with Pipercillin and tazobactam unless the benefit outweighs the risk.

Anticoagulants: Coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of heparin, oral anticoagulants, or other drugs that may affect the blood coagulation system or the thrombocyte function.

Vecuronium: Piperacillin when used concomitantly with vecuronium has been implicated in the prolongation of the neuromuscular blockade of vacuronium, piperacillin and tazobactam could produce the same phenomenon if given along with vecuronium. Due to their similar mechanism of action, it is expected that the neuromuscular blockade produced by any of the non-depolarizing muscle relaxants could be prolonged in the presence of piperacillin.

Methotrexate: Limited data suggests that co-administration of methotrexate and piperacillin may reduce the clearance of methotrexate due to competition for renal secretion. The impact of tazobactam on the elimination of methotrexate has not been evaluated. If concurrent therapy is necessary, serum concentrations of methotrexate as well as the signs and symptoms of methotrexate toxicity should be frequently monitored.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Piperacillin and tazobactam is contraindicated in patients with a history of allergic reactions to any of the penicillins, cephalosporins, or β -lactamase inhibitors.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Adverse events primarily involving the skin, including rash, pruritus and Purpura; the gastrointestinal system including diarrhea, Constipation, nausea, vomiting, Dyspepsia and Abdominal Pain; General disorders and administration site conditions including Fever, Injection site reaction (≤1%) and Rigors. (≤1%), Immune hypersensitivity reactions, anaphylactic/anaphylactoid reactions (including shock) (≤1%), Infections-Candidiasis and Pseudomembranous colitis (≤1%), Metabolism and nutrition disorders- Hypoglycemia (≤1%), Musculoskeletal and connective tissue disorders- Myalgia and Arthralgia (≤1%), Psychiatric disorders Insomnia, Vascular disorders- Phlebitis Thrombophlebitis(≤1%), Hypotension(≤1%), Flushing(≤1%), Respiratory, thoracic and mediastinal disorders- Epistaxis (≤1%).

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Piperacillin and tazobactam cross the placenta in humans. However, there are insufficient data with piperacillin and/or tazobactam in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. Piperacillin is excreted in human milk; tazobactam concentrations in human milk have not been studied. No information is available on the effects of piperacillin and tazobactam on the breastfed child or on milk production.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Serious hypersensitivity reactions (anaphylactic/anaphylactoid) reactions have been reported in patients receiving Piperacillin and tazobactam. Discontinue Piperacillin and tazobactam if a reaction occurs.

Piperacillin and tazobactam may cause severe cutaneous adverse reactions, such as Stevens- Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, and acute generalized exanthematous pustulosis. Discontinue Piperacillin and tazobactam for progressive rashes.

Hematological effects (including bleeding, leukopenia and neutropenia) have occurred. Monitor hematologic tests during prolonged therapy.

Nephrotoxicity in critically ill patients has been observed; the use of Piperacillin and tazobactam was found to be an independent risk factor for renal failure and was associated with delayed recovery of renal function as compared to other beta-lactam antibacterial drugs in a randomized, multicenter, controlled trial in critically ill patients. Based on this study, alternative treatment options should be considered in the critically ill population. If alternative treatment options are inadequate or unavailable, monitor renal function during treatment with Piperacillin and tazobactam.

Clostridium difficile associated diarrhea: Evaluate patients if diarrhea occurs.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

There have been post marketing reports of overdose with piperacillin/tazobactam. The majority of those events experienced, including nausea, vomiting, and diarrhea, have also been reported with the usual recommended dosages. Patients may experience neuromuscular excitability or convulsions if higher than recommended doses are given intravenously (particularly in the presence of renal failure). Treatment should be supportive and symptomatic according the patient's clinical presentation.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

বিকল্প ব্র্যান্ড: Piperacillin + Tazobactam

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Brodactam IV Infusion

(2 gm+0.25 gm)/vial

Piperacillin + Tazobactam

Synovia Pharma PLC.

৳ ৫৮৯.৯৬ ৳ ৬০২.০০ ২% ছাড় প্রতি ইউনিট

Brodactam IV Infusion

(4 gm+0.5 gm)/vial

Piperacillin + Tazobactam

Synovia Pharma PLC.

৳ ৯৮২.৯৪ ৳ ১০০৩.০০ ২% ছাড় প্রতি ইউনিট

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।